Chromadex

NutraCast: Why Ayana Bio CEO Frank Jaksch is betting on synbio

NutraCast: Why Ayana Bio CEO Frank Jaksch is betting on synbio

By Danielle Masterson

Synthetic biology technologies make it possible to create just about anything sustainably – including plants and fungal bioactives. Synbio has become a disruptive force that a growing number of companies are leaning into, including plant cell tech startup...

DSM Venturing strategically invests in ChromaDex

DSM Venturing strategically invests in ChromaDex

By Stephen DANIELLS

Chromadex has received equity financing from DSM Venturing, the corporate venture arm of Royal DSM, a move that will allow the Californian company to explore new topics and to accelerate its existing pipeline.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All